智核生物 SmartNuclide | 智核生物 SmartNuclide

OUR MISSION
+ 查看更多

Bring new hopes to patients through the most innovative nuclear diagnosis and treatment products.

SmartNuclide announced the completion of nearly RMB 100 million round B financing

Release date:2020-04-29

Read the text
The kick-off meeting of phase III clinical trial of rhTSH Drug SNA001 developed by SmartNuclide was held in Suzhou

Release date:2020-02-12

Read the text
SmartNuclide Biopharma Announces First Patient Treated in Phase 1/2 Clinical Trial of SNA001 for Well-Differentiated Thyroid Cancer

Release date:2019-02-12

Read the text
SmartNuclide’s SNA001 Receives NMPA’s First Investigational New Drug Approval for Recombinant Human TSH

Release date:2018-10-18

Read the text
Innovative Radiopharmaceutical Company SmartNuclide Closes Series Pre-A Financing

Release date:2018-03-07

Read the text